627 filings
ARS
2023 FY
PVCT
Provectus Biopharmaceuticals, Inc.
9 May 24
Annual report to shareholders
10:54am
DEFA14A
PVCT
Provectus Biopharmaceuticals, Inc.
6 May 24
Additional proxy soliciting materials
1:57pm
DEF 14A
PVCT
Provectus Biopharmaceuticals, Inc.
Definitive proxy
6 May 24
1:56pm
8-K
vq4fdi1d86r5lj64yj1
16 Apr 24
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
4:58pm
8-K
vt5ah
27 Mar 24
Entry into a Material Definitive Agreement
12:10pm
8-K
e77t3qkxs2d93u
26 Mar 24
Departure of Directors or Certain Officers
4:48pm
8-K
gegc 5atfsv
22 Feb 24
Regulation FD Disclosure
9:30am
8-K
8jm52
15 Feb 24
Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call
8:05am
8-K
1et0um1q59kavrlflv
22 Jun 23
Submission of Matters to a Vote of Security Holders
12:00am
8-K
odxt1a
21 Jun 23
Regulation FD Disclosure
9:50am
DEFA14A
gvco11y 4eisgimp
21 Jun 23
Additional proxy soliciting materials
9:45am
ARS
yt38i6 3nak
11 May 23
Annual report to shareholders
3:18pm
DEFA14A
0a0gw cftbzhb9at
1 May 23
Additional proxy soliciting materials
2:01pm